<PAGE>
FORM 4
[ ] Check box if no ------------------------------------
longer subject to OMB APPROVAL
Section 16. Form 4 or ------------------------------------
Form 5 obligations may OMB Number 3235-0287
continue. See Instruction 1(b) Expires: December 31, 2001
Estimated average burden
hours per response .............0.5
------------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
-------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Weisbach, Ph.D, Jerry
--------------------------------------------------------------------
(Last) (First) (Middle)
InKine Pharmaceutical Company, Inc.
Sentry Parkway West, Building 18
1787 Walton Road
--------------------------------------------------------------------
(Street)
Blue Bell, PA 19422
--------------------------------------------------------------------
(City) (State) (Zip)
-------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
InKine Pharmaceutical Company, Inc. (INKP)
-------------------------------------------------------------------------------
3. IRS or Social Security Number
of Reporting Person (Voluntary)
-------------------------------------------------------------------------------
4. Statement for Month/Year | 5. If Amendment, Date of
| Original (Month/Year)
11/2000 |
-------------------------------------------------------------------------------
6. Relationship of Reporting Person to Issuer (Check all applicable)
[ X ] Director [ ] 10% Owner
[ ] Officer [ ] Other (specify below)
(give title below)
-------------------------------------------------------------------------------
7. Individual or Joint/Group Reporting (Check Applicable Line)
X Form filed by One Reporting Person
---
Form filed by More than One Reporting Person
---
<PAGE>
-------------------------------------------------------------------------------
TABLE I - Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
-------------------------------------------------------------------------------
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security | 2. Transaction Date | 3. Transaction Code | 4. Securities Acquired (A) or Disposed
(Instr. 3) | (Month/Day/Year) | (Instr. 8) | of (D) (Instr. 3, 4 & 5)
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | Amount | (A) or| Price
| | | | (D) |
-----------------------------------------------------------------------------------------------------------------------------------
Common Stock | 11/07/00 | M | 2,500 | A | (FN1)
| (FN1) | | | |
===================================================================================================================================
</TABLE>
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Security | 5. Amount of Securities | 6. Ownership Form: | 7. Nature of Indirect Beneficial
(Instr. 3) | Beneficially Owned at | Direct (D) or | Ownership (Instr. 4)
| End of Month | Indirect (I) |
| (Instr. 3 & 4) | (Instr. 4) |
-----------------------------------------------------------------------------------------------------------------------------------
Common Stock | 12,500 | D |
===================================================================================================================================
</TABLE>
*If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 2270 (7/96)
<PAGE>
FORM 4 (continued)
-------------------------------------------------------------------------------
TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
-------------------------------------------------------------------------------
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security | 2. Conversion or | 3. Transaction Date | 4. Transaction | 5. Number of Derivative
(Instr. 3) | Exercise Price of | (Month/Day/Year) | Code (Instr.| Securities Acquired
| Derivative Security | | 8) | (A) or Disposed of
| | | | (D) (Instr. 3, 4 & 5)
| | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | (A) | (D)
-----------------------------------------------------------------------------------------------------------------------------------
Right to Receive Stock Grant | (FN1) | 11/07/00 | M | | 2,500
(Subject to performance goals) | | (FN1) | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
===================================================================================================================================
</TABLE>
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security | 6. Date Exercisable and | 7. Title and Amount of Underlying | 8. Price of Derivative
(Instr. 3) | Expiration Date | Securities (Instr. 3 & 4) | Security (Instr. 5)
| (Month/Day/Year) | |
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| Date | Expiration | Title | Amount or Number |
| Exercisable | Date | | of Shares |
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
Right to Receive Stock Grant | (FN1) | 11/07/09 | Common | 2,500 |
(Subject to performance goals) | | | Stock | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | | | |
===================================================================================================================================
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
<S> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative Security | 9. Number of Derivative | 10. Ownership of Derivative | 11. Nature of Indirect
(Instr. 3) | Securities Beneficially | Security: Direct (D) or | Beneficial Ownership
| Owned at End of Month | Indirect (I) (Instr. 4) | (Instr. 4)
| (Instr. 4) | |
-----------------------------------------------------------------------------------------------------------------------------------
Right to Receive Stock Grant | 2,500 | D |
(Subject to performance goals) | | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
-----------------------------------------------------------------------------------------------------------------------------------
| | |
===================================================================================================================================
</TABLE>
Explanation of Responses:
(FN1)The Issuer originally granted the Reporting Person the right to
receive these shares on November 8, 1999, pursuant to Issuer's 1999 Equity
Compensation Plan. The Reporting Person reported the original grant of this
right as a derivative security on the Reporting Person's Form 5 for the fiscal
year ended June 30, 2000. The vesting of this derivative security was subject to
the Reporting Person remaining a member of the Board of Directors of the Issuer
during the vesting period. For purposes of Section 16, following the expiration
of the vesting period, this derivative security is deemed to be converted into
shares of Common Stock of the Issuer on the Transaction Date.
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Robert F. Apple December 7, 2000
------------------------------------ ----------------
**Signature of Reporting Person Date
Robert F. Apple
as attorney-in-fact for
Jerry Weisbach, Ph.D.
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB number.
Page
SEC 2270 (7/96)
